Protara Therapeutics, Inc. (TARA) Net Income (Loss) Attributable to Parent USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Protara Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2024.
  • Protara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$11.1 M, a 22.7% decline year-over-year.
  • Protara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$42.5 M, a 33.9% increase year-over-year.
  • Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$40.4 M, a 38.7% increase from 2022.
  • Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$66 M, a 39.6% decline from 2021.
  • Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$47.3 M, a 39.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$42.5 M -$11.1 M -$2.05 M -22.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$40.4 M -$10.2 M +$28.7 M +73.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$69.2 M -$9.86 M -$2.17 M -28.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 -$67 M -$11.3 M -$2.76 M -32.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-03
Q1 2023 -$64.2 M -$9.05 M +$1.71 M +15.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$66 M -$39 M -$28.7 M -281% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$37.2 M -$7.69 M +$3.09 M +28.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$40.3 M -$8.54 M +$4.24 M +33.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$44.5 M -$10.8 M +$2.71 M +20.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 -$47.3 M -$10.2 M -$1.42 M -16.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 -$45.8 M -$10.8 M -$2.81 M -35.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$43 M -$12.8 M -$5.64 M -79% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$37.4 M -$13.5 M -$3.41 M -33.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$34 M -$8.81 M -$6.29 M -250% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 -$27.7 M -$7.97 M -$5.62 M -239% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$22.1 M -$7.14 M -$5.71 M -400% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$16.4 M -$10.1 M -$8.53 M -558% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$7.83 M -$2.52 M +$2.74 M +52.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$10.6 M -$2.35 M +$2.16 M +47.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$12.7 M -$1.43 M +$3.45 M +70.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$16.2 M -$1.53 M +$4.55 M +74.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$20.7 M -$5.26 M +$292 K +5.26% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$21 M -$4.51 M +$7.8 M +63.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 -$28.8 M -$4.88 M +$729 K +13% Apr 1, 2018 Jun 30, 2018 10-Q 2019-10-31
Q1 2018 -$29.5 M -$6.08 M +$417 K +6.42% Jan 1, 2018 Mar 31, 2018 10-Q 2019-10-31
Q4 2017 -$30 M -$5.55 M +$1.41 M +20.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$31.4 M -$12.3 M -$5.2 M -73.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$26.2 M -$5.61 M +$2.3 M +29.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$28.5 M -$6.5 M +$54 K +0.82% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$28.5 M -$6.96 M -$620 K -9.78% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-13
Q3 2016 -$27.9 M -$7.11 M -$1.72 M -32% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$26.2 M -$7.91 M -$2.83 M -55.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$23.3 M -$6.55 M -$1.97 M -43.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$21.4 M -$6.34 M -$13.6 M -188% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 -$7.8 M -$5.38 M -$202 K -3.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$7.6 M -$5.07 M -$2.51 M -97.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$5.09 M -$4.58 M -$1.75 M -61.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$3.34 M $7.23 M +$9.63 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$13 M -$5.18 M -$3.08 M -146% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$9.89 M -$2.56 M -$1.02 M -65.7% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$8.88 M -$2.83 M -$966 K -51.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$7.91 M -$2.4 M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-20
Q3 2013 -$2.1 M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-20
Q2 2013 -$1.55 M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-20
Q1 2013 -$1.87 M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.